Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia.

NCT00866762 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.

NCT NCT00866762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00866762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia.
Lead sponsor
Copenhagen University Hospital at Herlev
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2009
Completion date
December 31, 2012
Enrollment
60 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia, polycythemia vera